Cancer clinical trial - Genentech, Inc. GO40558

A Phase II, Open-Label, Multicenter, Randomized Study Of The Efficacy And Safety Of RO7198457 In Combination With Pembrolizumab Versus Pembrolizumab In Patients With Previously Untreated Advanced Melanoma

Drug

Pembrolizumab + or - RO7198457

Trial Type

Interventional

Phase

Phase 2

Condition

Melanoma

Keywords

Melanoma | Genentech